리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 06월
페이지 정보:영문 278 Pages
라이선스 & 가격 (부가세 별도)
한글목차
프란츠 셀 및 수분 증발량 측정기 세계 시장은 2030년까지 840만 달러에 이를 전망
2024년에 720만 달러로 추정되는 프란츠 셀 및 수분 증발량 측정기 세계 시장은 2024-2030년간 CAGR 2.5%로 성장하여 2030년에는 840만 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 프란츠 셀은 CAGR 3.1%를 나타내고, 분석 기간 종료시에는 570만 달러에 이를 것으로 예측됩니다. 수분 증발량 측정기 부문의 성장률은 분석 기간에 CAGR 1.4%로 추정됩니다.
미국 시장은 200만 달러로 추정, 중국은 CAGR 5.0%로 성장 예측
미국의 프란츠 셀 및 수분 증발량 측정기 시장은 2024년 200만 달러에 이른 것으로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 160만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 5.0%를 보일 전망입니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 0.9%와 1.9%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 1.4%로 성장할 것으로 예측됩니다.
세계의 프란츠 셀 및 수분 증발량 측정기 시장 - 주요 동향과 성장요인 정리
프란츠 셀 및 수분 증발량 측정기가 피부과 및 의약품 검사에서 점점 더 중요해지는 이유는 무엇인가?
프란츠 셀 및 수분 증발량 측정기는 피부 연구, 피부과학 제품 개발, 의약품 투과성 시험에 광범위하게 사용되는 특수 장비입니다. 프란츠 셀은 생체막(가장 일반적인 것은 피부)을 통과하는 약물 및 화합물의 수송 속도를 평가하기 위해 고안된 확산 시스템입니다. 외용제 및 경피용 약물의 제형을 시험하고 투과성, 효능 및 방출 프로파일을 결정하는 데 매우 중요합니다. 한편, 수분 증발량 측정기는 경표피 수분 손실(TEWL)을 측정하는 비침습적 도구로 피부 장벽 기능을 평가하고 외용제가 수분 공급 및 피부 완전성에 미치는 영향을 평가하는 데 도움이 됩니다.
이 두 가지 도구는 화장품 과학, 경피 약물 전달 연구 및 규제 테스트의 기초가 되고 있습니다. 정확하고 재현성이 높으며 동물을 사용하지 않는 시험 방법에 대한 요구가 높아짐에 따라 그 중요성이 더욱 커지고 있습니다. 규제 기관과 산업 시험 기관에서 체외 및 생체 외 시험 프로토콜로 전환함에 따라 피부 침투 및 수액 동태를 윤리적이고 효율적이며 정량적으로 평가할 수 있는 프란츠 확산 셀 및 수분 증발량 측정기의 중요성이 더욱 커지고 있습니다.
기술 발전으로 분석 정확도와 테스트 처리량이 어떻게 향상되고 있는가?
최신 프란츠 셀 시스템은 자동화, 온도 제어 정확도, 도너와 리셉터 인터페이스 재료의 강화 등의 이점을 가지고 있습니다. 개선된 유리 기구 구성, 모듈식 시스템, 다중 세포 확산 설정은 제약 및 화장품 제조업체가 대규모 비교 시험을 수행할 때 필수적인 더 높은 처리량으로 제제를 스크리닝할 수 있게 해줍니다. 합성 멤브레인 및 인간 또는 동물 피부 샘플과의 호환성을 통해 유연성을 높이고, 실시간 샘플링 포트의 통합으로 약물 투과에 대한 시간 경과에 따른 동역학 분석을 용이하게 합니다.
수분 증발량 측정기도 마찬가지로 디지털 디스플레이, 자동 보정, 피부 표면과의 일관된 접촉을 보장하는 인체공학적 디자인으로 진화하고 있습니다. 무선 핸드헬드 TEWL 측정기와 멀티 센서 어레이의 도입으로 임상시험 및 소비자 제품 시험에서 빠르고 반복 가능한 수분 장벽 평가가 가능해졌습니다. 이 기기들은 현재 디지털 데이터 로깅 시스템과 통합되어 연구자들이 다양한 피부 부위, 제품 유형 및 환자 상태에 대한 종합적인 수분 프로파일을 생성할 수 있도록 지원하고 있습니다. 이러한 기능 향상으로 프란츠 셀 및 수분 증발량 측정기는 피부 약리학 및 제품 안전성 검증을 위한 표준 분석 도구로서 그 유용성이 더욱 강화되고 있습니다.
시장 수요를 주도하는 산업과 이용 사례는?
프란츠 셀 및 수분 증발량 측정기의 주요 수요처는 제약회사, 화장품 및 퍼스널케어 제조업체, 연구소, 임상피부과학센터 등입니다. 제약사에서는 제네릭 경피제제의 생물학적 동등성 검증, 신규 피부 패치 평가, 경피제제 후보물질의 침투시험 등 의약품 개발 파이프라인에서 프란츠 셀이 사용되고 있습니다. 또한, 외용제 승인 시 in vitro 투과성 데이터가 점점 더 많이 요구되고 있는 가운데, 규제 당국 신청에서도 핵심적인 역할을 담당하고 있습니다.
화장품 제조업체는 피부 보습, 노화 방지, 유효 성분의 경피 흡수에 대한 주장을 뒷받침하기 위해 이 두 가지 도구를 사용합니다. 증기압계는 보습제, 자외선 차단제, 장벽 회복 제제의 제품 포지셔닝에 중요한 역할을 하며, 피부 장벽 개선에 대한 객관적인 데이터를 제공합니다. 학술 기관 및 위탁연구기관(CRO)도 특히 피부 독성 스크리닝, 제형 최적화, 소재 연구를 위한 중요한 사용자입니다. 또한, 스킨케어 진단 및 임상시험은 일반의약품(OTC) 및 피부화장품의 정량적 유효성 시험을 위해 이러한 툴을 활용하고 있습니다.
프란츠 셀 및 수분 증발량 측정기 시장의 주요 성장 촉진요인은 무엇인가?
프란츠 셀 및 수분 증발량 측정기 시장의 성장은 최종 용도의 혁신, 규제 변화, 시험 표준화와 관련된 여러 요인으로 인해 발생합니다. 주요 촉진요인은 특히 화장품 및 의약품 개발에서 동물 실험을 대체할 수 있는 체외 및 비침습적 테스트에 대한 수요가 증가하고 있다는 점입니다. 유럽, 북미, 아시아의 규제 당국은 프란츠 확산 시스템과 같은 효과적이고 재현성이 높은 모델을 이용한 투과성 및 피부 자극성 시험을 장려하고 있으며, 이는 시장 확대를 촉진하고 있습니다.
또한, 경피 흡수 및 방출 동역학에 대한 정확한 프로파일링이 필요한 경피 약물 전달 연구가 급증하고 있는 것도 한몫을 하고 있습니다. 마찬가지로, 고기능성 스킨케어 및 화장품의 보급으로 각 브랜드는 Vapour Meter와 같은 첨단 TEWL 측정 도구를 사용하여 광고 문구를 검증하고 있습니다. 또한, 임상 및 소비자 환경에서 피부 건강 모니터링 도구가 광범위하게 채택됨에 따라 휴대가 가능하고 사용자 친화적인 기기에 대한 관심이 증가하고 있는 것도 성장을 가속하고 있습니다. 실험실 자동화, 실시간 분석, 합성 피부 대체품에 대한 투자는 이러한 시스템의 상업적 실행 가능성을 더욱 향상시켜 프란츠 셀 및 수분 증발량 측정기를 현대 피부과학 및 제형 테스트에 필수적인 도구로 자리매김하고 있습니다.
부문
제품(Franz Cells, Vapometers);최종사용자(제약회사 최종사용자, 학술기관 및 연구기관 최종사용자, CRO/CDMO 최종사용자)
조사 대상 기업 예(총 44개사)
ABL&E-JASCO
Bionanoplus
Delfin Technologies Ltd.
Dissolution Accessories
IDM Instruments Pty Ltd.
JN Sciencetech
Orchid Scientific
PermeGear, Inc.
SES Analysesysteme GmbH
Teledyne Hanson Research
Thwing-Albert Instrument Company
Xenometrix AG
Biox Systems Ltd.
EnvisBE Solutions
Delfin USA
IndustryStock.com
HGR Industrial Surplus
Delfin Technologies-Teledyne Labs
Skinobs
Rycobel NV
AI 통합
우리는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global Franz Cells and Vapometers Market to Reach US$8.4 Million by 2030
The global market for Franz Cells and Vapometers estimated at US$7.2 Million in the year 2024, is expected to reach US$8.4 Million by 2030, growing at a CAGR of 2.5% over the analysis period 2024-2030. Franz Cells, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$5.7 Million by the end of the analysis period. Growth in the Vapometers segment is estimated at 1.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.0 Million While China is Forecast to Grow at 5.0% CAGR
The Franz Cells and Vapometers market in the U.S. is estimated at US$2.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Million by the year 2030 trailing a CAGR of 5.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.
Global Franz Cells and Vapometers Market - Key Trends & Drivers Summarized
Why Are Franz Cells and Vapometers Gaining Significance in Dermatological and Pharmaceutical Testing?
Franz cells and vapometers are specialized instruments used extensively in skin research, dermatological product development, and pharmaceutical permeability testing. Franz cells are diffusion systems designed to evaluate the rate of drug or compound transport across biological membranes-most commonly, skin. They are crucial in testing topical and transdermal drug formulations to determine their permeability, efficacy, and release profiles. Vapometers, on the other hand, are non-invasive tools used to measure transepidermal water loss (TEWL), helping assess skin barrier function and the impact of topical products on hydration and skin integrity.
Together, these tools have become foundational in cosmetic science, transdermal drug delivery research, and regulatory testing. Their relevance is increasing as the demand grows for high-precision, reproducible, and non-animal testing methodologies. The shift toward in vitro and ex vivo testing protocols across regulatory and industrial laboratories further reinforces the importance of Franz diffusion cells and vapometers in enabling ethical, efficient, and quantifiable assessments of skin penetration and moisture dynamics.
How Are Technological Advancements Enhancing Analytical Accuracy and Testing Throughput?
Modern Franz cell systems are benefiting from automation, temperature control precision, and enhanced donor-receptor interface materials. Improved glassware configurations, modular systems, and multi-cell diffusion setups are enabling higher-throughput screening of formulations, essential for pharmaceutical companies and cosmetic manufacturers running large-scale comparative tests. Compatibility with synthetic membranes and human or animal skin samples allows flexibility, while the integration of real-time sampling ports facilitates kinetic analysis of drug permeation over time.
Vapometers are similarly evolving with digital displays, automated calibration, and ergonomic designs that ensure consistent contact with the skin surface. The introduction of wireless, handheld TEWL meters and multi-sensor arrays allows fast, reproducible moisture barrier assessments in clinical and consumer product trials. These instruments are now being integrated with digital data logging systems, enabling researchers to generate comprehensive moisture profiles across different skin zones, product types, and patient conditions. These enhancements are strengthening the utility of both Franz cells and vapometers as standard analytical tools in dermatopharmacology and product safety validation.
Which Industries and Use Cases Are Driving Market Demand?
The primary demand for Franz cells and vapometers arises from pharmaceutical companies, cosmetic and personal care manufacturers, research laboratories, and clinical dermatology centers. In pharma, Franz cells are used in drug development pipelines to validate bioequivalence of generic transdermal formulations, evaluate novel skin patches, and conduct permeation studies on dermal drug candidates. They are also central to regulatory submissions, where in vitro permeability data is increasingly required for topical drug approvals.
Cosmetic manufacturers use both tools to support claims around skin hydration, anti-aging performance, and dermal absorption of active ingredients. Vapometers play a key role in product positioning for moisturizers, sunscreens, and barrier-repair formulations, providing objective data on skin barrier improvement. Academic institutions and contract research organizations (CROs) are also important users, especially for dermatotoxicity screening, formulation optimization, and materials research. Additionally, skin care diagnostics and clinical trials are adopting these tools for quantitative efficacy testing of over-the-counter (OTC) and dermocosmetic products.
What Are the Key Growth Drivers in the Franz Cells and Vapometers Market?
The growth in the Franz cells and vapometers market is driven by several factors related to end-use innovation, regulatory shifts, and testing standardization. A key driver is the rising demand for in vitro and non-invasive alternatives to animal testing, especially in cosmetic and pharmaceutical development. Regulatory authorities across Europe, North America, and Asia are increasingly encouraging permeability and skin irritation studies using validated, reproducible models like Franz diffusion systems, supporting market expansion.
Another driver is the surge in transdermal drug delivery research, which requires precise dermal absorption and release kinetics profiling. Similarly, the proliferation of high-performance skincare and cosmetic products is prompting brands to validate claims using advanced TEWL measurement tools like vapometers. Growth is also bolstered by the broader adoption of skin health monitoring tools in clinical and consumer environments, driving interest in portable, user-friendly instruments. Investments in lab automation, real-time analytics, and synthetic skin substitutes are further enhancing the commercial viability of these systems, positioning Franz cells and vapometers as essential tools in modern dermatological science and formulation testing.
SCOPE OF STUDY:
The report analyzes the Franz Cells and Vapometers market in terms of units by the following Segments, and Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 44 Featured) -
ABL&E-JASCO
Bionanoplus
Delfin Technologies Ltd.
Dissolution Accessories
IDM Instruments Pty Ltd.
JN Sciencetech
Orchid Scientific
PermeGear, Inc.
SES Analysesysteme GmbH
Teledyne Hanson Research
Thwing-Albert Instrument Company
Xenometrix AG
Biox Systems Ltd.
EnvisBE Solutions
Delfin USA
IndustryStock.com
HGR Industrial Surplus
Delfin Technologies - Teledyne Labs
Skinobs
Rycobel NV
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Tariff Impact on Global Supply Chain Patterns
Franz Cells and Vapometers - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Emphasis on Transdermal Drug Delivery Research Fuels Demand for Franz Diffusion Cells
Growth in Cosmetic and Dermatological Formulation Testing Expands Use of Vapometers
Expansion of Generic Drug Development Drives Demand for Bioequivalence Testing Platforms
Increasing Adoption of Skin Permeation Studies Across Pharmaceutical R&D Boosts Cell Usage
Technological Advancements in Flow-Through and Static Franz Cells Enhance Application Versatility
Surge in Demand for Non-Animal Testing Methods Strengthens Business Case for Diffusion Cells
Rising Investment in Controlled Release and Nano-Emulsion Technologies Fuels Market Penetration
Global Expansion of Contract Research Organizations (CROs) Supports Equipment Utilization
Development of Skin-Mimetic Membranes Enhances Realism and Reproducibility in Testing
Customization of Franz Cells for Ocular and Buccal Membrane Studies Broadens Market Applications
Automation and Digitization of Analytical Instruments Improve Accuracy and Throughput
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Franz Cells and Vapometers Market Analysis of Annual Sales in US$ for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Franz Cells and Vapometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 4: World 16-Year Perspective for Franz Cells and Vapometers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Franz Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Franz Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 7: World 16-Year Perspective for Franz Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Vapometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Vapometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 10: World 16-Year Perspective for Vapometers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Pharmaceuticals Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Pharmaceuticals Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 13: World 16-Year Perspective for Pharmaceuticals Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 16: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for CROs / CDMOs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for CROs / CDMOs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 19: World 16-Year Perspective for CROs / CDMOs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 21: USA Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 22: USA 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 23: USA Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 24: USA Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 25: USA 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
CANADA
TABLE 26: Canada Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 28: Canada 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 29: Canada Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 31: Canada 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
JAPAN
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 32: Japan Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 34: Japan 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 35: Japan Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 37: Japan 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
CHINA
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 38: China Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 39: China Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 40: China 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 41: China Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 42: China Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 43: China 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
EUROPE
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 44: Europe Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Franz Cells and Vapometers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 46: Europe 16-Year Perspective for Franz Cells and Vapometers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 49: Europe 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 52: Europe 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
FRANCE
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 53: France Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 54: France Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 55: France 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 57: France Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 58: France 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
GERMANY
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 59: Germany Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 61: Germany 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 64: Germany 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
ITALY
TABLE 65: Italy Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 67: Italy 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 70: Italy 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
UNITED KINGDOM
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 71: UK Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 72: UK Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 73: UK 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 75: UK Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 76: UK 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
SPAIN
TABLE 77: Spain Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 78: Spain Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 79: Spain 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 80: Spain Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 82: Spain 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
RUSSIA
TABLE 83: Russia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 84: Russia Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 85: Russia 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 86: Russia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 88: Russia 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
REST OF EUROPE
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
ASIA-PACIFIC
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Franz Cells and Vapometers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Franz Cells and Vapometers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
AUSTRALIA
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 104: Australia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 105: Australia Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 106: Australia 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 107: Australia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 109: Australia 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
INDIA
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 110: India Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 111: India Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 112: India 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 113: India Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 114: India Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 115: India 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
SOUTH KOREA
TABLE 116: South Korea Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 117: South Korea Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 118: South Korea 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 119: South Korea Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 123: Rest of Asia-Pacific Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
LATIN AMERICA
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 128: Latin America Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 129: Latin America Historic Review for Franz Cells and Vapometers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 130: Latin America 16-Year Perspective for Franz Cells and Vapometers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
TABLE 131: Latin America Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
ARGENTINA
TABLE 137: Argentina Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 138: Argentina Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 139: Argentina 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 140: Argentina Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
BRAZIL
TABLE 143: Brazil Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 144: Brazil Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 145: Brazil 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 146: Brazil Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
MEXICO
TABLE 149: Mexico Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 150: Mexico Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 151: Mexico 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 152: Mexico Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 156: Rest of Latin America Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 157: Rest of Latin America 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
MIDDLE EAST
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 161: Middle East Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 162: Middle East Historic Review for Franz Cells and Vapometers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 163: Middle East 16-Year Perspective for Franz Cells and Vapometers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
TABLE 164: Middle East Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
IRAN
TABLE 170: Iran Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 171: Iran Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 172: Iran 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 173: Iran Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 175: Iran 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
ISRAEL
TABLE 176: Israel Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 177: Israel Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 178: Israel 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 179: Israel Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 181: Israel 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
SAUDI ARABIA
TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 183: Saudi Arabia Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 184: Saudi Arabia 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 188: UAE Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 189: UAE Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 190: UAE 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 191: UAE Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 193: UAE 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 195: Rest of Middle East Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 196: Rest of Middle East 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
AFRICA
Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 200: Africa Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 201: Africa Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 202: Africa 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
TABLE 203: Africa Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
TABLE 205: Africa 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030